Overview

Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of BETOPTIC S and Timolol Gel-forming solution in pediatric patients. Patients will dose with study drug at 8 am and 8 pm daily for twelve weeks. Patients will have vision tested, slit lamp exam, blood pressure and pulse checks at each visit. Patients will have a dilated fundus exam and corneal measurements taken at first and last visit.

Phase:

Phase 3

Details

Lead Sponsor:

Alcon Research

Treatments:

Betaxolol
Pharmaceutical Solutions
Timolol